News

The Terra Race is a completely new gravel bike for Orbea that has been designed specifically for gravel racing, featuring more aggressive geometry and a focus on performance.
Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.
Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx Pharmaceuticals announced that the US FDA granted Fast Track designation to AMX0114.
China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several ...
Searching for terra firma in the biosimilars and non-original biologics market: insights for the coming decade of change In the global biosimilars market, the sands are shifting underfoot.
Kymera shared news of changes to the Sanofi collaboration minutes after disclosing an oncology deal with Gilead. The Big Biotech has committed up to $85 million in upfront and potential option ...
A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines ...
Corxel reported phase 2 data on an oral GLP-1 receptor agonist while Sciwind shared phase 3 data on its injectable treatment.
CERN engineer Sławosz Uznański-Wiśniewski and the rest of the Axiom-4 mission crew splashed down safely on the morning of 15 July at 11h31 (CEST) off the Californian coast aboard their Dragon ...